This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rödicker, F. Articles by Pützer, B. M. Search for Related Content PubMed PubMed Citation Articles by Rödicker, F. Articles by Pützer, B. M.

Therapeutic Efficacy of E2F1 in Pancreatic Cancer Correlates with TP73 Induction¹

Centre for Cancer Research and Cancer Therapy, Institute of Molecular Biology, University of Essen, Medical School, D-45122 Essen, Germany

Pancreatic cancer is particularly resistant to apoptosis by antineoplastic agents, which is partly attributable to the lack of functional p53. Here we show that E2F1 in combination with the most clinically efficient drug, gemcitabine, resulted in a strong induction of apoptosis independent of functional p53, whereas the effect of either therapy alone varied between different cell lines. Intratumoral injection of a helper-dependent adenovirus vector expressing E2F1 plus drug treatment resulted in a significant reduction of tumor volume. The therapeutic effect is directly correlated with the induction of the p53 homologue p73, suggesting that the recently discovered E2F1/p73 pathway plays a critical role in cancer therapy.

This article has been cited by other articles:

				M. Jenal, E. Trinh, C. Britschgi, A. Britschgi, V. Roh, S. A. Vorburger, A. Tobler, D. Leprince, M. F. Fey, K. Helin, et al. The Tumor Suppressor Gene Hypermethylated in Cancer 1 Is Transcriptionally Regulated by E2F1 Mol. Cancer Res., June 1, 2009; 7(6): 916 - 922. [Abstract] [Full Text] [PDF]

				T. Racek, S. Buhlmann, F. Rust, S. Knoll, V. Alla, and B. M. Putzer Transcriptional Repression of the Prosurvival Endoplasmic Reticulum Chaperone GRP78/BIP by E2F1 J. Biol. Chem., December 5, 2008; 283(49): 34305 - 34314. [Abstract] [Full Text] [PDF]

				M. Fiedler, F. Rodicker, V. Salucci, M. Lu, L. Aurisicchio, U. Dahmen, L. Jun, O. Dirsch, B. M. Putzer, F. Palombo, et al. Helper-Dependent Adenoviral Vector-Mediated Delivery of Woodchuck-Specific Genes for Alpha Interferon (IFN-{alpha}) and IFN-{gamma}: IFN-{alpha} but Not IFN-{gamma} Reduces Woodchuck Hepatitis Virus Replication in Chronic Infection In Vivo J. Virol., September 15, 2004; 78(18): 10111 - 10121. [Abstract] [Full Text] [PDF]

				W. Chen, J. Lee, S. Y. Cho, and H. A. Fine Proteasome-Mediated Destruction of the Cyclin A/Cyclin-Dependent Kinase 2 Complex Suppresses Tumor Cell Growth in Vitro and in Vivo Cancer Res., June 1, 2004; 64(11): 3949 - 3957. [Abstract] [Full Text] [PDF]

				M. S. Duxbury, H. Ito, M. J. Zinner, S. W. Ashley, and E. E. Whang Inhibition of Src Tyrosine Kinase Impairs Inherent and Acquired Gemcitabine Resistance in Human Pancreatic Adenocarcinoma Cells Clin. Cancer Res., April 1, 2004; 10(7): 2307 - 2318. [Abstract] [Full Text] [PDF]

				F. Rodicker and B. M. Putzer p73 Is Effective in p53-null Pancreatic Cancer Cells Resistant to Wild-type TP53 Gene Replacement Cancer Res., June 1, 2003; 63(11): 2737 - 2741. [Abstract] [Full Text] [PDF]

				A. Yokoi, J. Kuromitsu, T. Kawai, T. Nagasu, N. Hata Sugi, K. Yoshimatsu, H. Yoshino, and T. Owa Profiling Novel Sulfonamide Antitumor Agents with Cell-based Phenotypic Screens and Array-based Gene Expression Analysis Mol. Cancer Ther., February 1, 2002; 1(4): 275 - 286. [Abstract] [Full Text] [PDF]